Psychiatry & Neurology, Clinical Neurophysiology · Pomona, CA
NPI
1639381619
Since 2007
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
2895 N Towne Ave
Pomona, CA, 91767
Phone (702) 324-4039
Groups this clinician bills Medicare through
Medicare paid, 2024
$378K
6,297 services
Medicare patients, 2024
703
Average age 71
Drug cost, 2024
$12.3M
7,568 prescriptions
Company payments, 2025
$7,607
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sadiq L Altamimi was code 99439 (chronic, principal, and transitional care management), 2,412 times for 356 patients. In total Sadiq L Altamimi billed 6,297 services in 36 codes, and Medicare paid $378K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 2,412 | 356 | $37.84 | $91K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,968 | 379 | $48.11 | $95K |
| 99214 Office E&M - Established | Office | 432 | 297 | $91.04 | $39K |
| 99215 Office E&M - Established | Office | 215 | 190 | $132.51 | $28K |
| 95886 Electrical Nerve Conductivity | Office | 193 | 83 | $78.11 | $15K |
| 99454 E&M - Miscellaneous | Office | 183 | 25 | $40.73 | $7,454 |
| 99458 E&M - Miscellaneous | Office | 137 | 23 | $30.77 | $4,215 |
| 99457 E&M - Miscellaneous | Office | 127 | 31 | $38.76 | $4,922 |
| 95913 Electrical Nerve Conductivity | Office | 104 | 83 | $217.93 | $23K |
| 99205 Office E&M - New | Office | 100 | 100 | $149.39 | $15K |
| 95819 Neurologic | Office | 86 | 85 | $375.89 | $32K |
| 96139 Behavioral Health Services | Office | 81 | 41 | $31.40 | $2,543 |
| 99484 Behavioral Health Services | Office | 64 | 39 | $44.94 | $2,876 |
| 96138 Behavioral Health Services | Office | 41 | 41 | $30.51 | $1,251 |
| 96132 Behavioral Health Services | Office | 41 | 41 | $101.37 | $4,156 |
By year: 2022 $181K for 1,723 services; 2023 $363K for 5,182 services; 2024 $378K for 6,297 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sadiq L Altamimi prescribed most often to Medicare patients was Memantine Hcl, with 915 prescriptions and refills. In total Sadiq L Altamimi wrote 7,568 Medicare prescriptions that cost $12.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 915 | 1,490 | 231 | $22K |
| Donepezil Hcl Generic | 399 | 743 | 122 | $3,394 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 388 | 669 | 106 | $11K |
| Gabapentin Generic | 383 | 486 | 123 | $7,050 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 371 | 374 | 55 | $3.2M |
| Primidone Generic | 289 | 474 | 72 | $6,194 |
| Levetiracetam Generic | 246 | 486 | 64 | $9,391 |
| Rivastigmine Rivastigmine Tartrate | 237 | 321 | 50 | $8,396 |
| Lamotrigine Generic | 193 | 322 | 43 | $2,928 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 188 | 192 | 26 | $1.3M |
| Quetiapine Fumarate Generic | 176 | 284 | 41 | $2,263 |
| Clonazepam Generic | 157 | 171 | 40 | $683 |
| Baclofen Generic | 156 | 241 | 47 | $2,126 |
| Oxcarbazepine Generic | 155 | 256 | 26 | $9,133 |
| Botox Onabotulinumtoxina | 124 | 273 | 45 | $157K |
Brand drugs: - claims; generic drugs: 6,110 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sadiq L Altamimi $7,607 ($7,607 in general payments such as food, travel and fees) from 44 companies. The largest payer was UCB, Inc. with $1,060.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.